Levodopa Dose Equivalency in Parkinson's Disease: Updated Systematic Review and Proposals

Background To compare drug regimens across clinical trials in Parkinson's disease (PD) conversion formulae between antiparkinsonian drugs have been developed. These are reported in relation to levodopa as the benchmark drug in PD pharmacotherapy as ‘levodopa equivalent dose’ (LED). Currently, t...

Full description

Saved in:
Bibliographic Details
Published in:Movement disorders Vol. 38; no. 7; pp. 1236 - 1252
Main Authors: Jost, Stefanie T., Kaldenbach, Marie‐Ann, Antonini, Angelo, Martinez‐Martin, Pablo, Timmermann, Lars, Odin, Per, Katzenschlager, Regina, Borgohain, Rupam, Fasano, Alfonso, Stocchi, Fabrizio, Hattori, Nobutaka, Kukkle, Prashanth Lingappa, Rodríguez‐Violante, Mayela, Falup‐Pecurariu, Cristian, Schade, Sebastian, Petry‐Schmelzer, Jan Niklas, Metta, Vinod, Weintraub, Daniel, Deuschl, Guenther, Espay, Alberto J., Tan, Eng‐King, Bhidayasiri, Roongroj, Fung, Victor S.C., Cardoso, Francisco, Trenkwalder, Claudia, Jenner, Peter, Ray Chaudhuri, K., Dafsari, Haidar S.
Format: Journal Article
Language:English
Published: Hoboken, USA John Wiley & Sons, Inc 01.07.2023
Wiley Subscription Services, Inc
Subjects:
ISSN:0885-3185, 1531-8257, 1531-8257
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Be the first to leave a comment!
You must be logged in first